4//SEC Filing
HOLMER ALAN F 4
Accession 0000950170-24-073710
CIK 0001595097other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:24 PM ET
Size
16.4 KB
Accession
0000950170-24-073710
Insider Transaction Report
Form 4
HOLMER ALAN F
Director
Transactions
- Exercise/Conversion
Common Stock, par value $0.0001 per share
2024-06-14$30.00/sh+1,667$50,010→ 5,829 total - Exercise/Conversion
Options to purchase common stock
2024-06-14−1,667→ 0 totalExercise: $30.00Exp: 2024-07-09→ Common Stock (1,667 underlying)
Footnotes (2)
- [F1]This amount includes 2,783 unvested RSUs that were granted on May 30, 2024 and will vest 100% on the one-year anniversary from the date of grant.
- [F2]The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and is fully vested.
Documents
Issuer
Corbus Pharmaceuticals Holdings, Inc.
CIK 0001595097
Entity typeother
Related Parties
1- filerCIK 0001329585
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 4:24 PM ET
- Size
- 16.4 KB